Figure 2 | Scientific Reports

Figure 2

From: Elderly onset age is associated with low efficacy of first anti-tumor necrosis factor treatment in patients with inflammatory bowel disease

Figure 2

Cumulative events rate leading the discontinuation of anti-TNF treatment. (a) Cumulative discontinuation rate in Elderly-EO, Elderly-NEO, and Non-elderly. (b) Cumulative SAE rate during first anti-TNF treatment in Elderly-EO, Elderly-NEO, and Non-elderly. Anti-TNF anti-tumor necrosis factor, EO elderly onset, IBD inflammatory bowel disease, NEO non-elderly onset, SAE serious adverse event.

Back to article page